Cincinnati Edition: With nation In crisis, Trump returns to campaign trail
UC's Tia Sheree Gaynor shares thoughts on president's political moves and other topics
Tia Sherèe Gaynor, an assistant professor in the Department of Political Science, participated in an hour-long, panel discussion on WVXU’s Cincinnati Edition on Thursday, June 25. Among the topics discussed were upcoming election, COVID-19 and race relations.
“It seems like we're just in this uncomfortable and complicated space where we're fighting for so many different things,” Gaynor told WVXU.
Gaynor’s research focuses on issues related to social (in)justice, cultural competency and social equity within a U.S. and global context, particularly as it relates to underrepresented and marginalized populations.
Featured image: President Donald Trump arrives on stage to speak at a campaign rally at the BOK Center, Saturday, June 20, 2020, in Tulsa, Okla. Photo/Evan Vucci/AP
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.